Promising new molecule could transform obesity treatment
Researchers at Stanford University have discovered a natural molecule capable of suppressing appetite and promoting fat loss, potentially paving the way for a new generation of obesity medications.
Scientists at Stanford University School of Medicine have identified a natural molecule, dubbed 'BRP', which has shown significant potential in animal studies for weight loss. The discovery was facilitated by artificial intelligence, allowing researchers to screen thousands of biological compounds.
According to media reports, the molecule works differently than current drugs like Ozempic by targeting a specific area of the brain called the hypothalamus, which regulates hunger and metabolism, rather than affecting multiple organs.
Tests on mice and pigs showed a significant reduction in food intake, with subjects losing fat while preserving muscle mass. Notably, the animals did not exhibit common digestive side effects, raising hopes for a more precise and better-tolerated treatment.
Researchers emphasize that the discovery is in its early stages. Future efforts will focus on understanding the molecule's cellular interactions and conducting clinical trials to determine its safety and efficacy for human use.